Health costs of the UK-US trade deal on pharmaceuticals

BMJ 2026 Open access

Read full text
Authors: Samuel H. Cross, K Claxton, Andrew Hill
DOI: 10.1136/bmj-2026-340588
Cited by: 10
References: 11

Abstract

Samuel Cross, Karl Claxton, and Andrew Hill argue that diversion of billions of NHS funding to pay more for new drugs under the UK-US trade deal will harm public health and result in thousands of excess deaths

Fields of Study & Subjects

Global Public Health Policies and Epidemiology Pharmaceutical Economics and Policy Global Healthcare and Medical Tourism

Publication details

Journal / source
BMJ
Publisher
BMJ
Volume
394
Pages
e340588–e340588
Publication date
1 July 2026
Language
EN